Sensory-Motor Systems Lab, Institute of Robotics and Intelligent Systems, ETH Zurich, Switzerland.
J Neuroeng Rehabil. 2009 Dec 17;6:46. doi: 10.1186/1743-0003-6-46.
Robot-assisted therapy offers a promising approach to neurorehabilitation, particularly for severely to moderately impaired stroke patients. The objective of this study was to investigate the effects of intensive arm training on motor performance in four chronic stroke patients using the robot ARMin II.
ARMin II is an exoskeleton robot with six degrees of freedom (DOF) moving shoulder, elbow and wrist joints. Four volunteers with chronic (>or= 12 months post-stroke) left side hemi-paresis and different levels of motor severity were enrolled in the study. They received robot-assisted therapy over a period of eight weeks, three to four therapy sessions per week, each session of one hour.Patients 1 and 4 had four one-hour training sessions per week and patients 2 and 3 had three one-hour training sessions per week. Primary outcome variable was the Fugl-Meyer Score of the upper extremity Assessment (FMA), secondary outcomes were the Wolf Motor Function Test (WMFT), the Catherine Bergego Scale (CBS), the Maximal Voluntary Torques (MVTs) and a questionnaire about ADL-tasks, progress, changes, motivation etc.
Three out of four patients showed significant improvements (p < 0.05) in the main outcome. The improvements in the FMA scores were aligned with the objective results of MVTs. Most improvements were maintained or even increased from discharge to the six-month follow-up.
Data clearly indicate that intensive arm therapy with the robot ARMin II can significantly improve motor function of the paretic arm in some stroke patients, even those in a chronic state. The findings of the study provide a basis for a subsequent controlled randomized clinical trial.
机器人辅助疗法为神经康复提供了一种有前途的方法,特别是对于严重至中度受损的中风患者。本研究的目的是使用 ARMin II 机器人研究 4 名慢性中风患者的手臂强化训练对运动表现的影响。
ARMin II 是一种具有六个自由度(DOF)的外骨骼机器人,可移动肩部、肘部和腕关节。四名患有慢性(> 12 个月的中风)左侧偏瘫且运动严重程度不同的志愿者参加了这项研究。他们接受了为期八周的机器人辅助治疗,每周三到四次,每次治疗一小时。患者 1 和 4 每周接受四次一小时的训练,患者 2 和 3 每周接受三次一小时的训练。主要结果变量是上肢评估的 Fugl-Meyer 评分(FMA),次要结果变量是 Wolf 运动功能测试(WMFT)、Catherine Bergego 量表(CBS)、最大随意扭矩(MVT)以及一份关于 ADL 任务、进展、变化、动机等的问卷。
四名患者中有三名(p < 0.05)主要结果显著改善。FMA 评分的改善与 MVTs 的客观结果一致。大多数改善在出院后到六个月随访期间得到保持甚至增加。
数据清楚地表明,使用 ARMin II 机器人进行强化手臂治疗可以显著改善一些中风患者,甚至是慢性患者的患侧手臂运动功能。研究结果为随后的对照随机临床试验提供了依据。